Arvinas · 5 hours ago
Senior Director, Clinical Scientist -Neurodegenerative disease
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating diseases. The Senior Director, Clinical Scientist will provide scientific support for Global Clinical Development activities, including developing clinical documents and collaborating with various teams to ensure successful study execution.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Lead the development of clinical study protocol synopses and full protocols, including engage with subject matter experts (internal and external) on study design elements and endpoints
Contribute to the clinical portion of investigator brochures review for consistency and applicability
Contribute in the writing and review of clinical study reports (CSRs), data safety update reports (DSURs), annual reports and regulatory briefing books
Manage development of internal and external presentations/publications (manuscripts, posters, etc.) of clinical study data
Participate in publication planning
Contribute to writing of departmental working processes (SOPs, templates, etc)
Assist clinical research physician in developing clinical development plans
Contribute to the development of data collection tools, statistical analysis plans (SAPs), case report forms (CRFs)
Collaborate with cross-functional study team to ensure timely study start-up including CRO selection, Data monitoring committee/Independent Radiology Reviewer activities, Central Lab on-boarding etc
Lead development of Medical Monitor Plans
Perform ongoing clinical data review and critical analysis of study data including partnering with clinical research physician
Partner with Clinical Operations, Translational Medicine, Pharmacovigilance, Data management and other functional team members at assure quality and timely study conduct and monitoring
Provide support as needed for clinical and scientific issues that may arise during study execution
Work closely with biostatisticians and programmers to plan analyses of clinical data
Support data summaries for leadership, advisory board meetings, etc
Perform literature searches and critically review and summarize the relevant scientific, drug development and medical literature to support document development, such as the investigator brochure, protocol design, clinical study report, competitive assessments, etc
Provide scientific/medical supportive materials to in-house staff and external consultants in the indications being studied
Identify and review literature that addresses specific topics of interest relevant to Arvinas drug candidates
Qualification
Required
Advanced, doctoral level degree preferred such as PhD, MD, MSc/MPH, PharmD, BS/ MS with relevant professional experience may be considered
10+ years of experience within a pharmaceutical company environment required
Neurodegenerative/neuromuscular disease experience /educational background required
Advanced knowledge of GCP/ICH, drug development process, study design, statistics, clinical operations in the neurodegenerative/neuromuscular disease setting required
Excellent project management, communication and organizational skills required with demonstrated success in leading projects and interacting with cross-functional teams
Passionate commitment and a strong team player
Ability to work independently and reliably deliver objectives of high quality in a timely manner
The duties of this role are generally conducted in a home or corporate office environment. Employees must be able, with or without accommodation, to use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours
Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship
Benefits
Group medical, vision and dental coverage
Group and supplemental life insurance
And much more
Company
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Funding
Current Stage
Public CompanyTotal Funding
$461.6MKey Investors
Logos CapitalNextech Invest
2025-08-15Post Ipo Equity
2023-11-27Post Ipo Equity· $350M
2018-09-26IPO
Recent News
Canaan Partners
2025-12-03
2025-11-11
Company data provided by crunchbase